Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System
- PMID: 19002981
- PMCID: PMC3449892
- DOI: 10.1023/A:1008192709549
Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System
Abstract
The expression of recombinant proteins with the Semliki Forest Virus (SFV) system has been scaled up to bioreactor scale. As a model protein for this study the human 5-HT(3) receptor was chosen. The gene for the receptor was subcloned into the SFV expression plasmid pSFV1. Virus production by in vivo packaging and production of the recombinant protein was scaled up, the latter to a reactor volume of 11.5 l. A Vibromix(TM) agitation system was chosen to overcome aggregation problems of BHK cells in suspension. In the process, cells were first grown to a density of 10(6) cells/ml, the medium was then exchanged with fresh medium and the culture was infected with the recombinant virus at an estimated multiplicity of infection of 30. 24 h post infection we measured an expression level of 3 million functional 5-HT(3) receptors per cell. For harvesting, the cells were pelleted by centrifugation. The receptor protein was purified in a single step (Hovius et al., 1998) by exploiting the hexa-His tag at minimal protein loss (51% yield). Experiments to optimise expression resulted in yields up to 8 million receptors per cell, when the pH of a suspension culture was controlled at pH 7.3. Rapid virus generation and protein production, high protein yields as well as successful large scale application have made the SFV expression system attractive to produce large quantities of recombinant protein in a very short time. After optimisation of the expression conditions (in particular by setting the pH at 7.3), yields were increased twofold.
Similar articles
-
Expression of ligand-gated ion channels with the Semliki Forest virus expression system.J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):115-26. doi: 10.3109/10799899709036597. J Recept Signal Transduct Res. 1997. PMID: 9029484
-
An optimization study for expression of the rabies virus glycoprotein (RVGP) in mammalian cell lines using the Semliki Forest virus (SFV).J Biotechnol. 2019 Oct 10;304:63-69. doi: 10.1016/j.jbiotec.2019.08.012. Epub 2019 Aug 20. J Biotechnol. 2019. PMID: 31442500
-
High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system.Eur J Biochem. 1994 Sep 15;224(3):917-21. doi: 10.1111/j.1432-1033.1994.00917.x. Eur J Biochem. 1994. PMID: 7523121
-
Semliki forest virus-based expression for versatile use in receptor research.J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):229-40. doi: 10.1081/rrs-120014598. J Recept Signal Transduct Res. 2002. PMID: 12503618 Review.
-
Semliki Forest virus vectors for gene therapy.Expert Opin Biol Ther. 2003 Aug;3(5):771-7. doi: 10.1517/14712598.3.5.771. Expert Opin Biol Ther. 2003. PMID: 12880377 Review.
Cited by
-
High yield and efficient expression and purification of the human 5-HT3A receptor.Acta Pharmacol Sin. 2015 Aug;36(8):1024-32. doi: 10.1038/aps.2015.35. Epub 2015 Jun 15. Acta Pharmacol Sin. 2015. PMID: 26073329 Free PMC article.
-
Hydrophobic photolabeling studies identify the lipid-protein interface of the 5-HT3A receptor.Biochemistry. 2009 Oct 6;48(39):9278-86. doi: 10.1021/bi901208j. Biochemistry. 2009. PMID: 19715355 Free PMC article.
-
Viral and Synthetic RNA Vector Technologies and Applications.Mol Ther. 2016 Sep;24(9):1513-27. doi: 10.1038/mt.2016.143. Epub 2016 Jul 5. Mol Ther. 2016. PMID: 27377044 Free PMC article. Review.
References
-
- Aleshkov S, Abraham CR, Zannis V. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta: relevance to Alzheimer's disease. Biochemistry. 1997;36:10571–10580. - PubMed
-
- Arudchandran R, Brown MJ, Song JS, Wank SA, Haleem-Smith H, Rivera J. Polyethylene glycol-mediated infection of non-permissive mammalian cells with Semliki Forest virus: application to signal transduction studies. J Immunol Methods. 1999;222:197–208. - PubMed
-
- Barrett N, Mitterer A, Mundt W, Eibl J, Eibl M, Gallo RC, Moss B, Dorner F. Large scale production and purification of a vaccinia recombinant derived HIV-1 GP160 and analysis of its immunogenicity. Aids Res Hum Retroviruses. 1989;5:159–172. - PubMed
-
- Berglund P, Sjödberg M, Garoff H, Atkins JG, Sheahan BJ, Liljeström P. Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Bio/Technology. 1993;11:916–920. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials